Ketamine and depression: a mechanism of the antidepressant effect reveal
Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
10.06.2022
Research, science & health
The “Brain to Market” Summer School
The "Brain to Market" Summer School is an intensive 5-day training program to learn through practice the key skills of health entrepreneurship. Offered by the Open Brain School, the Paris Brain Institute's training organization, since 2015, this year...
10.03.2022
Teaching & training
Genetics of early-onset parkinsonism with intellectual disability
A research team from the Paris Brain Institute (Inserm/CNRS/Sorbonne University/AP-HP) just identified mutations in familial cases with early-onset Parkinsonism and intellectual disability. Genetic studies on two affected siblings pairs highlighted...
09.29.2022
Research, science & health
An open-source algorithm to help Alzheimer's disease diagnosis
The diagnosis of atypical forms of Alzheimer's disease is still sometimes difficult. Researchers from Paris Brain Institute have developed an automated algorithm to correlate the specificities of brain lesions with the symptoms associated with these...
09.18.2022
Research, science & health
Homage to Charles Duyckaerts
It is with deep sadness that we inform you of the death of our colleague and friend, Prof. Charles Duyckaerts, who left us on the evening of Saturday, August 6, after several years of battling illness.
08.10.2022
Institutional
Computational model of brain complexity and function, a new research perspective
In a recent paper, published in Reviews of Modern Physics, Charley Presigny and Fabrizio de Vico Fallani (Inria) from the ARAMIS team from the Paris Brain Institute present a new mathematical model to decipher the brain organization and function in...
08.08.2022
Research, science & health
The 2021 Annual Report of the Paris Brain Institute is available
In 2021, the Institute’s teams were at the origin of important scientific breakthroughs, with the indispensable support of the technological platforms, whose restructuring has made it possible to meet everyone’s needs as well as possible.
07.20.2022
Institutional
Alzheimer's disease, a complex genetic susceptibility
Although Alzheimer's disease is not inherited in 95% of cases, nearly 75 genetic susceptibility factors - that is, factors that increase the risk to develop the disease - or protective factors - that decrease the probability to be affected - have...
07.11.2022
Research, science & health
The Paris Brain Institute is looking for its new Chief Executive Officer
The Institut du Cerveau – Paris Brain Institute is an internationally renowned neuroscience research institute located in Paris, France, on the campus of the Pitié-Salpêtrière hospital, providing world class expertise in basic and clinical...
07.08.2022
Institutional
The Paris Brain Institute at the FENS Forum 2022
The next forum organized by FENS (Federation of European Neuroscience Societies) will be held in Paris from 9 to 13 July 2022. The Paris Brain Institute’s researchers are mobilized for the largest ever symposium on neurosciences in Europe.
07.07.2022
Events
Status Epilepticus: new biomarkers to improve the prognosis of patients admitted to the ICU
A major neurological emergency, status epilepticus is defined as a persistent epileptic seizure. Exposing patients to irreversible brain lesions that cause serious cognitive sequelae, it requires intensive care, which may lead to sedation (artificial...
07.06.2022
Research, science & health
3D mapping of the meningeal lymphatic network reveals new mysteries
Jean-Léon Thomas' group (Inserm, Paris Brain institute) just published a 3D mapping of the meningeal lymphatic network and the associated cerebrospinal fluid (CSF) drainage, both in mice and in humans. Beyond the identification of highly conserved...
07.05.2022
Research, science & health